Long-term ritlecitinib was generally well tolerated among patients aged 12 years and older with alopecia areata and showed clinically meaningful efficacy through 3 years. Treatment with ritlecitinib ...

placebo in adults with severe alopecia areata, according to phase 3 data presented here. Oral ivarmacitinib significantly induced hair regrowth at 24 weeks compared with placebo in adults with ...

Approximately 40% of patients with AA experience first onset by 20 years of age. 2 "Early onset alopecia areata can be more severe, leading to extensive hair loss that frequently does not improve ...

If you have alopecia areata, you are probably no stranger to a roller coaster of emotions. It’s true that this condition isn’t life-threatening and doesn't cause physical pain. But it can ...

Alopecia areata is a skin disease that makes you lose patches or large sections of hair on your scalp and body. It's not life-threatening, but it can be life-altering. Hair is a part of your identity.

Nektar Therapeutics has concluded target enrolment in the Phase IIb REZOLVE-AA trial of its investigational biologic therapy, rezpegaldesleukin, for treating individuals with severe-to-very-severe ...